Skip to main content
SpringerLink
Log in

Vaccination against Herpes Simplex Virus Infections

  • Chapter
The Herpesviruses

Part of the book series: The Viruses ((VIRS))

Abstract

Many viral diseases have been effectively prevented by the use of vaccines, and these accomplishments make it desirable and logical to develop a vaccine that will prevent the diseases caused by herpes simplex virus (HSV), a requirement made urgent by the increased incidence of genital herpes infections in recent years.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Allen, W. P., and Rapp, F., 1982, Concept review of genital herpes vaccines, J. Infect. Dis. 145:413–421.

    Article  PubMed  CAS  Google Scholar 

  • Anderson, S. G., Hamilton, J., and Williams, S., 1950, An attempt to vaccinate against herpes simplex, Aust. J. Exp. Biol. Med. Sci. 28:579–584.

    Article  PubMed  CAS  Google Scholar 

  • Anderson, W. A., and Kilbourne, E. D., 1961, Immunization of mice with inactivated herpes simplex virus, Proc. Soc. Exp. Biol. Med. 107:518–520.

    PubMed  CAS  Google Scholar 

  • Andonov, P., Dundarov, S., and Bakalov, B., 1979, Preparation and prophylactic therapeutical effect of Bulgarian inactivated polyvalent herpes vaccines, Acta Med. Bulg. Eng. 6:55–64.

    Google Scholar 

  • Ashley, R. L., and Corey, L., 1983, Development of antibodies to a herpes simplex virus type 2 (HSV-2) subunit vaccine in seronegative and seropositive volunteers, 8th International Herpes Virus Workshop, Oxford, England.

    Google Scholar 

  • Barinsky, I. F., Shubladze, A. K., Kasparov, A. A., Zaitseva, N. S., and Zdanov, V. M., 1983, Inactivated herpes virus vaccine and cell immunity reactions in the study of its efficacy, 8th International Herpes Virus Workshop, Oxford, England.

    Google Scholar 

  • Baron, A., Rozan, Fouanon, and Guillot, 1966, Herpes cornéen, traitement par vaccin spécifique, Bull. Soc. Ophthalmol. Fr. 66:137–142.

    CAS  Google Scholar 

  • Beale, J., 1983, Hybrid vaccinia virus for mass hepatitis immunization?, Nature (London) 302:476–477.

    Article  CAS  Google Scholar 

  • Benson, H., and Epstein, M. D., 1975, The placebo effect: A neglected asset in the care of patients, J. Am. Med. Assoc. 232:1227.

    Article  Google Scholar 

  • Berman, P. W., Dowbenco, D., Lasky, L. A., and Simonsen, C. C., 1983, Detection of antibodies to herpes simplex virus with a continuous cell line expressing cloned glycoprotein D, Science 222:524–527.

    Article  PubMed  CAS  Google Scholar 

  • Bertland, A. U., and Lampson, G. P., 1982, Herpes simplex type 1 subunit vaccine and process for its preparation, European Patent Application No. 81401407.2.

    Google Scholar 

  • Biberstein, H., and Jessner, M., 1958, Experiences with herpin in recurrent herpes simplex, together with a review and analysis of the literature on the use of CNS as a virus antigen carrier, Dermatologica 117:267–287.

    Article  PubMed  CAS  Google Scholar 

  • Bierman, S. M., 1976, BCG immunoprophylaxis of recurrent herpes progenitalis, Arch. Dermatol. 112:1410–1415.

    Article  PubMed  CAS  Google Scholar 

  • Blank, H., and Haines, H. G., 1973, Experimental human reinfection with herpes simplex virus, J. Invest. Dermatol. 61:223–225.

    Article  PubMed  CAS  Google Scholar 

  • Brain, R. T., 1936, Biological therapy in virus diseases, Br. J. Dermatol. Syph. 48:21–26.

    Article  Google Scholar 

  • Brückner, R., 1970, Erste persönliche Erfahrungen mit dem Vaccin antiherpétique “Diamant,” Ophthalmologic 161:104–107.

    Article  Google Scholar 

  • Bubola, D., and Mancosu, A., 1967, Indagine clinica ed immunologica di 30 malati di erpete récidivante dopo vaccinazione specifica, G. Ital. Dermatol. 108:107.

    CAS  Google Scholar 

  • Cappel, R., 1976, Comparison of the humoral and cellular immune responses after immunization with live UV inactivated herpes simplex virus and a subunit vaccine and efficacy of these immunizations, Arch. Virol. 32:29–35.

    Article  Google Scholar 

  • Cappel, R., de Cuyper, F., and de Braekeler, J., 1979, Antibody and cell mediated immunity to a DNA free herpes simplex subunit vaccine, Dew. Biol. Stand. 43:381–385.

    CAS  Google Scholar 

  • Cappel, R., de Cuyper, F., and Rickaert, F., 1980, Efficacy of a nucleic acid free herpetic subunit vaccine, Arch. Virol. 65:15–23.

    Article  PubMed  CAS  Google Scholar 

  • Cappel, R., Sprecher, S., and de Cuyper, F., 1982a, Immune responses to DNA free herpes simplex proteins in man, Dev. Biol. Stand. 52:345–350.

    PubMed  CAS  Google Scholar 

  • Cappel, R., Sprecher, S., Rickaert, F., and de Cuyper, F., 1982b, Immune response to a DNA free herpes simplex vaccine in man, Arch. Virol. 73:61–67.

    Article  PubMed  CAS  Google Scholar 

  • Carter, C. A., Hartley, C. E., Skinner, G. R. B., Turner, S. P., and Easty, D. L., 1981, Experimental ulcerative herpetic keratitis. IV. Preliminary observations on the efficacy of a herpes simplex subunit vaccine, Br. J. Ophthalmol. 65:679–682.

    Article  PubMed  CAS  Google Scholar 

  • Chan, W. L., 1983, Protective immunization of mice with specific HSV-1 glycoproteins, Immunology 49:343–352.

    PubMed  CAS  Google Scholar 

  • Chanock, R. M., 1983, Vaccines—New developments, Arch. Virol. 76:163–177.

    Article  Google Scholar 

  • Chapin, H. B., Wong, S. C., and Reapsome, J., 1962, The value of tissue culture vaccine in the prophylaxis of recurrent attacks of herpetic keratitis, Am. J. Ophthalmol. 54:255–265.

    PubMed  CAS  Google Scholar 

  • Cohen, G. H., Dietzschold, B., Ponce de Leon, M., Long, D., Golub, E., Varichio, A., and Eisenberg, R. F., 1983, Construction of an antigenic determinant of herpes simplex virus glycoprotein D which stimulates production of neutralizing antibody, 8th International Herpes Virus Workshop, Oxford, England.

    Google Scholar 

  • Corey, L., Adams, H. G., Brown, Z. A., and Holmes, K. K., 1983, Genital herpes simplex virus infections: Clinical manifestations, course and complications, Ann. Intern. Med. 98:958–972.

    PubMed  CAS  Google Scholar 

  • Degos, R., and Touraine, R., 1964, Traitement de l’herpès récidivant par un vaccin spécifique, Bull. Soc. Fr. Dermatol. Syphiligr. 71:161–166.

    PubMed  CAS  Google Scholar 

  • Dietzschold, B., and Cohen, G. H., 1984, Synthesis of an antigenic determinant of the herpes simplex virus (HSV) glycoprotein D which stimulates the production of virus neutralizing antibody and which confers protection against a lethal challenge infection of HSV in: Modern Approaches to Vaccines —Molecular and Chemical Basis of Virus Virulence and Immunospecificity, Cold Spring Harbor Laboratory, Cold Spring Harbor, New York.

    Google Scholar 

  • Dundarov, S., Andonov, P., Bakalov, B., Nechev, K., and Tomov, C., 1982, Immunotherapy with inactivated polyvalent herpes vaccines, Dev. Biol. Stand. 52:351–358.

    PubMed  CAS  Google Scholar 

  • Dundarov, S., Andonov, P., Bakalov, B., Tomov, S., Nechev, K., Kazandjiev, S., Antonov, L., Dundarova, D., and Todorova, R., 1983, Therapy with herpes simplex vaccines, 8th International Herpes Virus Workshop, Oxford, England.

    Google Scholar 

  • Eisenberg, R. J., Wilcox, W., Long, D., Ponce de Leon, M., Pereira, L., Long, D., and Cohen, G. H., 1982, Purification of glycoprotein D of herpes simplex virus types 1 and 2 by use of monoclonal antibodies, J. Virol. 41:1099–1104.

    PubMed  CAS  Google Scholar 

  • Eisenberg, R. J., Wilcox, W., Long, D., Ponce de Leon, M., and Cohen, G. H., 1983, Expression of herpes simplex virus glycoprotein D in E. coli transformed with bacteriophage M 13, 8th International Herpes Virus Workshop, Oxford, England.

    Google Scholar 

  • Fanta, D., Kraft, D., and Söltz-Szöts, J., 1974, Problematik und Therapie des rezivierenden Herpes Simplex, Z. Hautkr. 49:597–606.

    PubMed  CAS  Google Scholar 

  • Fenyves, A., and Strupp, L., 1982, Heat resistant infectivity of herpes simplex virus revealed by viral transfection, Intervirology 17:228–239.

    Article  PubMed  CAS  Google Scholar 

  • Frank, D. B., 1938, Formalized herpes virus therapy and the neutralizing substance in herpes simplex, J. Invest. Dermatol. 1:267–282.

    Article  CAS  Google Scholar 

  • Gauri, K. K., Pressler, K., and Chenk, K. D., 1981, Procédé pour la préparation de nouveaux mutants de virus de l’herpes type 1 et type 2, mutants obtenus et leur application à la fabrication de vaccins contre les infections herpétiques, Demande de Brevet d’Invention No. 81 11576, Institut National de la Propriété Industrielle, Paris.

    Google Scholar 

  • Goldman, L., 1961, Reactions of an auto inoculation for recurrent herpes simplex, Arch. Dermatol. 84:1025–1026.

    Article  PubMed  CAS  Google Scholar 

  • Gunby, P., 1983, Genital herpes research: Many aim to tame maverick virus, J. Am. Med. Assoc. 250:2417–2427.

    Article  CAS  Google Scholar 

  • Henocq, E., 1967, Vaccin anti-herpétique, Rev. Med. (Paris) numéro spécial 8:695–708.

    Google Scholar 

  • Henocq, E., 1972a, Hypersensibilités cutanées mixtes avec présence d’anticorps précipitants dans le sérum, Rev. Fr. Allergol. 12:35–41.

    PubMed  CAS  Google Scholar 

  • Henocq, E., 1972b, Actualité du vaccin anti-herpétique, Thérapeutique 48:485–488.

    PubMed  CAS  Google Scholar 

  • Henocq, E., de Rudder, J., Maurin, J., and Lepine, P., 1964, Essai de thérapeutique de l’herpes récidivant par un vaccin préparé en culture cellulaire et inactivé par les rayons ultraviolets. II. Essais cliniques, Sem. Hop. 40:1474–1480.

    Google Scholar 

  • Hilfenhaus, J., and Moser, H., 1981, Prospects for a subunit vaccine against herpes simplex virus infections, Behring Inst. Mitt. 69:45–56.

    CAS  Google Scholar 

  • Hilfenhaus, J., Christ, H., Köhler, R., Moser, H., Kirchner, H., and Levy, H. B., 1981, Pro-tectivity of herpes simplex virus antigens: Studies in mice on the adjuvant effect of PICLC and on the dependence of protection on T cell competence, Med. Microbiol. Immunol. 169:225–235.

    Article  PubMed  CAS  Google Scholar 

  • Hilleman, M. R., Larson, V. M., Lehman, E. D., Salerno, R. A., Conard, R. A., Conard, P., and McLean, A., 1982, Subunit herpes simplex virus vaccine, in: The Human Herpesviruses: An Interdisciphnary Perspective (A J. Nahmias, W. R. Dowdle, and R. F. Schin-azi, eds.), pp. 503–506, Elsevier/North-Holland, Amsterdam.

    Google Scholar 

  • Hull, R. N., and Peck, F. B., 1966, Vaccination against herpes virus infections, Pan Am. Health Org. Sci. PUbl. 147:266–275.

    Google Scholar 

  • Jarisch, R., and Sandor, I., 1977, MIF in der Therapiekontrolle von Herpes simplex recidivans: Behandlung mit Levamisole, BCG, Urushiol und Herpes Antigen Vaccine, Arch. Dermatol Res. 258:1151–159.

    Google Scholar 

  • Jawetz, E., Allende, M. E., and Coleman, V. R., 1955, Studies on herpes simplex virus. VI. Observations of patients with recurrent herpetic lesions infected with herpes simplex virus or their antigens, Am. J. Med. Sci. 229:477.

    Article  PubMed  CAS  Google Scholar 

  • Kaerner, H. C., Schröder, C. H., Ott-Hartmann, A., Kümmel, G., and Kirchner, H., 1983, Genetic variability of herpes simplex virus: Development of a pathogenic variant during passaging of a non pathogenic herpes simplex virus type 1 virus strain in mouse brain, J. Virol. 46:83–93.

    PubMed  CAS  Google Scholar 

  • Katzin, D. S., Connor, J. D., Wilson, L. A., and Sexton, R. S., 1967, Experimental herpes simplex infection in the owl monkey, Proc. Soc. Exp. Biol. Med. 125:391–398.

    PubMed  CAS  Google Scholar 

  • Kern, A. B., and Schiff, B. L., 1959, Small pox vaccinations in the management of recurrent herpes simplex: A controlled evaluation, J. Invest. Dermatol. 33:99.

    Article  PubMed  CAS  Google Scholar 

  • Kern, A. B., and Schiff, B. L., 1964, Vaccine therapy in recurrent herpes simplex, Arch. Dermatol. 89:844–845.

    Article  PubMed  CAS  Google Scholar 

  • Kit, S., Quavi, H., Dubbs, D. R., and Otsuka, H., 1983, Attenuated marmoset herpes virus isolated from recombinants of virulent marmoset herpes virus and hybrid plasmids, J. Med. Virol. 12:25–36.

    Article  PubMed  CAS  Google Scholar 

  • Kitagawa, K., 1973, Therapy of herpes simplex with heat inactivated herpes virus hominis type 1 and type 2, Z. Hautkr. 48:533–535.

    PubMed  CAS  Google Scholar 

  • Kitces, E. N., Morahan, P. S., Tew, F. G., and Murray, B. K., 1977, Protection from oral herpes simplex virus infection by a nucleic acid-free virus vaccine, Infect. Immun. 16:955–960.

    PubMed  CAS  Google Scholar 

  • Klein, R. J., Buimovici-Klein, E., Moser, H., Moucha, R., and Hilfenhaus, J., 1981, Efficacy of a virion envelope herpes simplex virus vaccine against experimental skin infections in hairless mice, Arch. Virol. 68:73–80.

    Article  PubMed  CAS  Google Scholar 

  • Kutinova, L., Vonka, V., and Slichtova, V., 1980, Immunogenicity of subviral herpes simplex virus preparations: Protection of mice against intraperitoneal infection with live virus, Acta Virol. (Engl. Ed.) 24:391–398.

    CAS  Google Scholar 

  • Kutinova, L., Slichtova, V., and Vonka, V., 1982, Subviral herpes simplex vaccine, Dew. Biol. Stand. 52:313–319.

    CAS  Google Scholar 

  • Larson, V., and Lehman, E. D., 1979, Antigenic, immunogenic herpes virus subunit and process for preparing it, European Patent Application No. 78400098.6.

    Google Scholar 

  • Lazar, M. P., 1956, Vaccination for recurrent herpes simplex infection: Initiation of a new disease site following the use of unmodified material containing the live virus, Arch. Dermatol. 73:70–71.

    Article  CAS  Google Scholar 

  • Lepine, P., and de Rudder, J., 1964, Bilan des résultats obtenus dans le traitement de l’herpès au moyen d’un nouveau vaccin inactivé: Les Entretiens de Bichat, Sem. Ther. 40:469–474.

    PubMed  CAS  Google Scholar 

  • Levaditi, C., 1926, L’herpès et le zona, Masson, Paris.

    Google Scholar 

  • Levaditi, C., and Harvier, P., 1920, Etude expérimentale de l’encéphalite léthargique, Ann. Inst. Pasteur (Paris) 34:911–972.

    Google Scholar 

  • Lipschütz, B., 1921, Untersuchungen über die Etiologie der Krankenheiten des Herpes-gruppe, Arch. Dermatol. Syphilol. 136:428–482.

    Article  Google Scholar 

  • Löwenstein, A., 1919, Aetiologische Untersuchungen über den Fieberhaften Herpes, Med. Wschr. 28:769–770.

    Google Scholar 

  • London, W. T., Catalano, L. W., Nahmias, A.J., Fucillo, D. A., and Sever, J. L., 1971, Genital herpes virus hominis type 2 infection of monkeys, Obstet. Gynecol. 37:501–509.

    PubMed  CAS  Google Scholar 

  • Macher, E., 1957, Zur Behandlung des chronisch-rezivierenden Herpes simplex, Z. Haut Geschlechtskr. 23:18–22.

    CAS  Google Scholar 

  • Macotela-Ruiz, E., 1973, Vacuna anti-herpetica y unguento con 5 Yodo-2-desoxyuridine en el herpes simple récidivante cutaneo mucoso, Prensa Med. Mex. 38:362–367.

    PubMed  CAS  Google Scholar 

  • Melendez, L. V., Espana, C., Hunt, R. D., Daniel, M. D., and Garcia, F. G., 1969, Natural herpes simplex infection in owl monkey (Aotus trivirgatus), Lab. Anim. Care 19:38–45.

    PubMed  CAS  Google Scholar 

  • Mocarski, E. S., Post, L. E.; and Roizman, B., 1980, Molecular engineering of the herpes simplex virus genome: Insertion of a second L-S junction into the genome causes additional genome inversions, Cell 22:243–255.

    Article  PubMed  CAS  Google Scholar 

  • Moreschi, G. I., and Ennis, F. A., 1982, Prevention and treatment of HSV infections, in: The Human Herpesviruses: An Interdisciplinary Perspective, (A. J. Nahmias, W. R. Dowdle, and R. F. Schinazi, eds.), pp. 441–446, Elsevier/North-Holland, Amsterdam.

    Google Scholar 

  • Morse, L. S., Buchman, R. G,. Roizman, B., and Schaffer, P. A., 1977, Anatomy of herpes simplex virus DNA. D.C., Apparent exclusion of some parental DNA arrangements in the generation of intertypic (HSV 1 x HSV 2) recombinants, J. Virol. 24:231–248.

    PubMed  CAS  Google Scholar 

  • Mullin, W. B., 1966, Unpublished data cited in Hull and Peck (1966).

    Google Scholar 

  • Nagler, F. P. O., 1946, A herpes skin test reagent from amniotic fluid, Aust. J. Exp. Biol. Med. Sci. 24:103–105.

    Article  PubMed  CAS  Google Scholar 

  • Nasemann, T., 1965, Die Behandlung der Infektionen durch das Herpes simplex virus, Ther. Ggw. 104:294–309.

    PubMed  CAS  Google Scholar 

  • Nasemann, T., 1970, Neuere Behandlungsmethoden unterschiedlicher Herpes simplex Infektionen, Arch. Klin. Exp. Dermatol. 237:234–237.

    Article  PubMed  CAS  Google Scholar 

  • Nasemann, T., 1973, Herpes progenitalis durch Herpes simplex virus type 1?, Hautarzt 24:367–368.

    PubMed  CAS  Google Scholar 

  • Nasemann, T., and Schaeg, G., 1973, Herpes simplex virus, type II: Mikrobiologie und klinische Erfahrungen mit einer abgetöten Vaccine, Hautarzt 24:133–139.

    PubMed  CAS  Google Scholar 

  • Nicolau, S., and Banciu, A., 1924, Herpès récidivant expérimental chez Phomme, CR. Soc. Biol 90:138–140.

    Google Scholar 

  • Nicolau, S., and Poincloux, P., 1923, Quelques caractères de l’herpès expérimental chez Phomme, CR. Soc. Biol. 89:779–781.

    Google Scholar 

  • Offret, G., Payrau, P., de Rudder, J., Pouliquen, Y., Faure, J. P., and Cuq, G., 1965, De l’application du vaccin inactivé dans la kératite herpétique, Arch. Ophthalmol. 25:287–300.

    CAS  Google Scholar 

  • Osborn, J. E., 1979, Viral vaccines under development: A third generation, Adv. Exp. Med. Biol. 118:61–82.

    PubMed  CAS  Google Scholar 

  • Panscherewski, D., and Rhode, B., 1957, Zur Serologie und Therapie des Herpes simplex reeidivans, Hautarzt 13:275–278.

    Google Scholar 

  • Paoletti, E., and Panicali, D., 1984, Genetically engineered pox viruses as live recombinant vaccines, in: Modern Approaches to Vaccines —Molecular and Chemical Basis of Virus Virulence and Immunospecificity, Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y., pp. 295–299.

    Google Scholar 

  • Parks, W. P., and Rapp, F., 1975, Prospects for herpes virus vaccination: Safety and efficacy considerations, Prog. Med. Virol. 21:188–206.

    PubMed  CAS  Google Scholar 

  • Paulian, D., 1932, Le virus herpétique et la sclérose latérale amyotropique, Bull. Acad. Med. Roum. 107:1462–1467.

    Google Scholar 

  • Petersen, E. E., 1977, Onkogenität von Herpes simplex Viren and Lupidon, Z. Hautkr. 52:417–426.

    PubMed  CAS  Google Scholar 

  • Poffenberger, K. L., Tabares, E., and Roizman, B., 1980, Characterization of a viable, non-inverting herpes simplex virus 1 genome derived by insertion and deletion of sequences at the junction of components L and S, Proc. Natl. Acad. Sci. USA 80:2690–2694.

    Article  Google Scholar 

  • Post, L. E., and Roizman, B., 1981, A generalized technique for deletion of specific genes in large genomes: a gene 22 of herpes simplex virus 1 is not essential for growth, Cell, 25:227–232.

    Article  PubMed  CAS  Google Scholar 

  • Post, L. E., and Roizman, V., 1981, A generalized technique for deletion of specific genes in large genomes: a gene 22 of herpes simplex virus 1 is not essential for growth in cell culture, Cell 25:227–232.

    Article  PubMed  CAS  Google Scholar 

  • Post, L. E., Mackem, S., and Roizman, B., 1981, The regulation of alpha genes of herpes simplex virus: Expression of chimeric genes produced by fusion of thymidine kinase with a gene promoters, Cell 34:555–556.

    Article  Google Scholar 

  • Pouliquen, Y., Jollivet, J., and Argenton, C., 1966, Mode d’utilisation du vaccin anti-herpétique en pratique ophtalmologique, Arch. Ophthalmol. 26:565–568.

    CAS  Google Scholar 

  • Rajcani, J., Kutinova, L., and Vonka, V., 1980, Restriction of latent herpes virus infection in rabbits immunized with subviral herpes simplex virus vaccine, Acta Virol. (Engl. Ed.) 24:183–193.

    CAS  Google Scholar 

  • Rawls, W. E., and Campione-Piccardo, J., 1982, Epidemiology of herpes simplex virus type 1 and type 2 infections, in: The Human Herpesviruses: An Interdisciplinary Perspective (A. J. Nahmias, W. R. Dowdle, and R. F. Schinazi, eds.), pp. 137–152, Elsevier/ North-Holland, Amsterdam.

    Google Scholar 

  • Remy, W., Antoniadis, G., Bockendahl, H., and Remy, B., 1975, Antikörpertiter-Verläufe bei Patienten mit rezivierenden Herpes simplex virus Infektionen unter Vakzinationen mit Hitzinaktivierten Herpes Viren, Z. Hautkr. 51:103–107.

    Google Scholar 

  • Roizman, B., Warren, J., Thuning, C. A., Fanshaw, M. S., Norrild, B., and Meignier, B., 1982, Application of molecular genetics to the design of live herpes simplex virus vaccines, Dev. Biol. Stand. 53:287–304.

    Google Scholar 

  • Santoianni, P., 1966, La nostra esperienza sullo terapia dell-erpete semplice récidivante con un vaccino specifico, Minerva Dermatol. 41:30–35.

    PubMed  CAS  Google Scholar 

  • Schmersahl, P., and Rüdiger, G., 1975, Behandlungsergebnisse mit dem Herpes simplex Antigen Lupidon, H., bzw. Lupidon G., Z. Hautkr. 50:105–112.

    PubMed  CAS  Google Scholar 

  • Schneider, J., and Rhode, B., 1972, Zur Antigen Therapie des rezidivierenden Herpes simplex mit dem Herpes simplex Impfstoff Lupidon H und G, Z. Haut Geschlechtskr. 47:973–980.

    CAS  Google Scholar 

  • Schneweis, K. E., Gruber, J., Hilfenhaus, J., Möslein, A., Kayser, M., and Wolff, M. H., 1981, The influence of different modes of immunization on the experimental genital herpes simplex virus infection of mice, Med. Microbiol. Immunol. 169:269–279.

    Article  PubMed  CAS  Google Scholar 

  • Schubladze, A. K., Zaitseva, N. S., Maevskaya, T. M., Cheglakov, Y. A., Muravieve, T. V., Slepova, O. S., Kasparov, A. A., and Barinsky, I. F., 1978, (On the mechanism of specific vaccine therapy in ocular herpes simplex), Vopr. Virusol. 1:63–68.

    Google Scholar 

  • Scriba, M., 1981, Vaccination against herpes simplex virus: Animal studies on the efficacy against acute, latent and recurrent infections, in: Herpetische Augenkrankungen (R. Sundmacher, ed.), Springer-Verlag (Bergmann), Berlin.

    Google Scholar 

  • Skinner, G., Williams, D. R., Buchan, A., Whitney, J., Harding, M., and Bodfisch, K., 1978, Preparation and efficacy of an inactivated subunit vaccine (NFU1 BHK) against type 2 herpes simplex virus infection, Med. Microbiol. Immunol. 166:119–132.

    Article  PubMed  CAS  Google Scholar 

  • Skinner, G., Buchan, A., Hartley, C. E., Turner, S. P., and Williams, D. R., 1980a, The preparation, efficacy and safety of “antigenoid” vaccine NFU1 (S- L+) MRC towards prevention of herpes simplex virus infections in human subjects, Med. Microbiol. Immunol. 169:39–51.

    Article  PubMed  CAS  Google Scholar 

  • Skinner, G. R. B., Williams, D. R., Moles, A. W., and Sargent, A., 1980b, Prepubertal vaccination of mice against experimental infection of the genital tract with type 2 herpes simplex virus, Arch. Virol. 64:329–338.

    Article  PubMed  CAS  Google Scholar 

  • Skinner, G. R. B., Woodman, G. B., Hartley, C. E., Buchan, A., Fuller, A., Durham, J., Synnot, M., Clay, J. C., Melling, J., Wiblin, C., and Wilkins, G., 1982a, Preparation and im-munogenicity of vaccine Ac NFU1 (S-) MRC towards the prevention of herpes genitalis, Br. J. Vener. Dis. 58:381–386.

    PubMed  CAS  Google Scholar 

  • Skinner, G. R. B., Woodman, G., Hartley, C., Buchan, A., Fuller, A., Wiblin, C., Wilkins, G., and Melling, J., 1982b, Early experience with “antigenoid” vaccine Ac NFU1 (S-) MRC towards prevention or modification of herpes genitalis, Dev. Biol. Stand. 52:333–344.

    PubMed  CAS  Google Scholar 

  • Skinner, G. R. B., Buchan, A., Williams, D., Marsden, J., Hartley, C., Wilbanks, G., Turyk, M., and Namkoong, E. S., 1982c, Immunogenicity and protective efficacy in a rhesus monkey model of vaccine Ac NFU1 (S-) MRC against primary type 2 herpes simplex virus infection, Br. J. Exp. Pathol. 63:378–387.

    PubMed  CAS  Google Scholar 

  • Slichtova, V., Kutinova, L., and Vonka, V., 1980, Immunogenicity of subviral herpes simplex virus type 1 preparation: Protection of mice against intradermal challenge with type 1 and type 2 viruses, Arch. Virol. 66:207–214.

    Article  PubMed  CAS  Google Scholar 

  • Slichtova, V., Kutinova, L., and Vonka, V., 1982, Immunogenicity of a subviral herpes simplex type 1 preparation: Reduction of recurrent disease in mice, Arch. Virol. 71:75–78.

    Article  PubMed  CAS  Google Scholar 

  • Smith, G. L., Mackett, M., and Moss, B., 1983a, Infectious vaccinia virus recombinants that express hepatitis B virus surface antigen, Nature (London) 302:490–495.

    Article  CAS  Google Scholar 

  • Smith, G. L., Mackett, M., Murphy, B., and Moss, B., 1984, Vaccinia virus recombinants expressing genes from pathogenic agents have potential as live vaccines, in: Modern Approaches to Vaccines —Molecular and Chemical Basis of Virus Virulence and Im-munospecificity, Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y., pp. 313–317.

    Google Scholar 

  • Söltz-Szöts, f., 1960, Neue Methode einer spezifischen Vaccination bei rezivierendem Herpes simplex, Hautartz 11:465–467.

    Google Scholar 

  • Söltz-Szöts, J., 1971, Die Behandlung des rezivierenden Herpes simplex, Z. Haut Ges-chlechtskr. 46:267–272.

    Google Scholar 

  • Steppert, A., 1956, Zur Behandlung des rezivierenden Herpes simplex, Wien. Klin. Woch-enschr. 68:452–453.

    CAS  Google Scholar 

  • Teissier, P., Gastinel, P., and Reilly, J., 1922, L’inoculabilité de l’herpes; présence du virus kératogène dans les lésions, C.R. Soc. Biol. 87:638–649.

    Google Scholar 

  • Teissier, P., Gastinel, P., et Reilly, J., 1923, L’inoculabilité de l’herpès chez les encéphali-tiques, C.R. Soc. Biol. 88:255–256.

    Google Scholar 

  • Thompson, R. L., and Stevens, J., 1983, Replication at body temperature selects a neuro-virulent herpes simplex virus type 2, Infect. Immun. 41:855–857.

    PubMed  CAS  Google Scholar 

  • Thomson, T. A., Hilfenhaus, J., Moser, H., and Morahan, P. S., 1983, Comparison of effects of adjuvants on efficacy of virion envelope herpes simplex virus vaccine against labial infection of Balb/c mice, Infect. Immun. 41:556–562.

    PubMed  CAS  Google Scholar 

  • Thornton, B., Griffiths, J. B., and Walkland, A., 1982, Herpes simplex vaccine using cell membrane associated antigen in animal model, Dev. Biol. Stand. 50:201–206.

    Google Scholar 

  • Tureau, 1924, L’herpès expérimental de l’homme, Thèse No. 364, Legrand, Paris.

    Google Scholar 

  • Vallée, G., 1980, Traitement de l’herpès récurrent par le vaccin antipoliomyélitique Sabin, Thèse Médecine, Université de Paris VII.

    Google Scholar 

  • von Rodovsky, J., Dbaly, V., and Benda, R., 1971, Präventivbehandlung des rezivierenden Herpes mit einer aus Kaninchennierenzellen hergestellt Formolvakzine, Dermatol. Monatsschr. 157:701–708.

    PubMed  CAS  Google Scholar 

  • Watson, R. J., Weis, J. H., Salstrom, J. S., and Endquist, L. W., 1983, Herpes simplex virus type 1 glycoprotein D gene: Nucleotide sequence and expression in Escherichia coli, Science 218:381–384.

    Article  Google Scholar 

  • Weis, J. H., Endquist, L. W., Salstrom, J. S., and Watson, R. J., 1983, An immunologically active chimaeric protein containing herpes simplex virus type 1 glycoprotein D, Nature (London) 302:72–74.

    Article  CAS  Google Scholar 

  • Weitgasser, H., 1973, Neue Behandlungsmöglichkeiten des Herpes simplex in der dermatologischen Praxis, Hautarzt 24:298–301.

    PubMed  CAS  Google Scholar 

  • Weitgasser, H., 1977, Kontrollierte klinische Studie mit den Herpes Antigenen Lupidon H und Lupidon G, Z. Hautkr. 52:625–628.

    CAS  Google Scholar 

  • Wheeler, C. E., 1960, Herpes simplex virus, Arch. Dermatol. 82;141–149.

    Google Scholar 

  • Wise, T. G., Pavan, P. R., and Ennis, F. A., 1977, Herpes simplex virus vaccines, J. Infect. Dis. 136:706–711.

    Article  PubMed  CAS  Google Scholar 

  • Woodman, C. B. J., Buchan, A., Fuller, A., Hartley, C., Skinner, G. R. B., Stocker, D., Sugrue, D., Clay, J. C., Wilkins, G., Wiblin, C., and Melling, J., 1983, Efficacy of vaccine Ac NFU (S-) MRC5 given after an initial clinical episode in the prevention of herpes genitalis, Br. J. Vener. Dis. 59:311–313.

    PubMed  CAS  Google Scholar 

  • Yoshino, K., Yanagi, K., and Abe, K., 1982, Efficacy of intradermal administration of herpes simplex virus subunit vaccine, Microbiol. Immunol. 26:753–757.

    PubMed  CAS  Google Scholar 

  • Zweerink, H. J., Martinez, D., Lynch, R. J., and Stanton, L. W., 1981, Immune responses in mice against herpes simplex virus: Mechanisms of protection against facial and ganglionic infections, Infect. Immun. 31:267–275.

    PubMed  CAS  Google Scholar 

  • Zygraich, N., and Huygelen, C., 1974, Vaccin contre le virus Herpès simplex type 2, procédé pour sa préparation et ses applications, Brevet d’invention No. 74.10112, Institut National de la Propriété Industrielle, Paris.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Institut Mérieux, Marcy l’Etoile, Charbonnières les Bains, France

    Bernard Meignier

Authors
  1. Bernard Meignier
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. University of Chicago, Chicago, Illinois, USA

    Bernard Roizman

  2. Sloan-Kettering Institute for Cancer Research, New York, New York, USA

    Carlos Lopez

Rights and permissions

Reprints and permissions

Copyright information

© 1985 Plenum Press, New York

About this chapter

Cite this chapter

Meignier, B. (1985). Vaccination against Herpes Simplex Virus Infections. In: Roizman, B., Lopez, C. (eds) The Herpesviruses. The Viruses. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-8021-8_13

Download citation

  • DOI: https://doi.org/10.1007/978-1-4615-8021-8_13

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4615-8023-2

  • Online ISBN: 978-1-4615-8021-8

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation